English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Flavopiridol inhibits TGF-b-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2 Journal article
Rostam M.A., Shajimoon A., Kamato D., Mitra P., Piva T.J., Getachew R., Cao Y., Zheng W., Osman N., Little P.J.. Flavopiridol inhibits TGF-b-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2[J]. Journal of Pharmacology and Experimental Therapeutics, 2018, 365(1), 156-164.
Authors:  Rostam M.A.;  Shajimoon A.;  Kamato D.;  Mitra P.;  Piva T.J.; et al.
Favorite | TC[WOS]:25 TC[Scopus]:24 | Submit date：2018/12/21
The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle Journal article
Rostam M.A., Kamato D., Piva T.J., Zheng W., Little P.J., Osman N.. The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle[J]. Cellular Signalling, 2016, 28(8), 956.
Authors:  Rostam M.A.;  Kamato D.;  Piva T.J.;  Zheng W.;  Little P.J.; et al.
Favorite | TC[WOS]:42 TC[Scopus]:45 | Submit date：2018/10/30
Atherosclerosis  Glycosaminoglycan  Signalling  Smad  Transforming Growth Factor-β  Vascular Smooth Muscle  
Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease Journal article
Rostam M.A., Piva T.J., Rezaei H.B., Kamato D., Little P.J., Zheng W., Osman N.. Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease[J]. Clinical and Experimental Pharmacology and Physiology, 2015, 42(2), 117-124.
Authors:  Rostam M.A.;  Piva T.J.;  Rezaei H.B.;  Kamato D.;  Little P.J.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:24 | Submit date：2018/12/21
Atherosclerosis  Cardiovascular Disease  Peptidyl-prolyl Isomerase  Pin1  
Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells Journal article
Kamato D., Rostam M.A., Piva T.J., Babaahmadi Rezaei H., Getachew R., Thach L., Bernard R., Zheng W., Little P.J., Osman N.. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells[J]. The Journal of pharmacy and pharmacology, 2014, 66(12), 1722-1733.
Authors:  Kamato D.;  Rostam M.A.;  Piva T.J.;  Babaahmadi Rezaei H.;  Getachew R.; et al.
Favorite | TC[WOS]:24 TC[Scopus]:25 | Submit date：2018/12/21
Cell Signalling  Serine/threonine Kinase  Smad Linker Region  Smads  Transforming Growth Factor-β  
Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells Journal article
Little P.J., Rostam M.A., Piva T.J., Getachew R., Kamato D., Guidone D., Ballinger M.L., Zheng W., Osman N.. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells[J]. Journal of Pharmacy and Pharmacology, 2013, 65(7), 1055-1063.
Authors:  Little P.J.;  Rostam M.A.;  Piva T.J.;  Getachew R.;  Kamato D.; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15 | Submit date：2018/12/21
Atherosclerosis  Biglycan  Imatinib  Pdgfβ Receptor Kinase Activity  Pdgfβ Receptor Phosphorylation